91 related articles for article (PubMed ID: 8074464)
1. Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 alleles.
Runnebaum IB; Yee JK; Kieback DG; Sukumar S; Friedmann T
Anticancer Res; 1994; 14(3A):1137-44. PubMed ID: 8074464
[TBL] [Abstract][Full Text] [Related]
2. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
[TBL] [Abstract][Full Text] [Related]
3. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
[TBL] [Abstract][Full Text] [Related]
4. Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53.
Runnebaum IB; Wang S; Kreienberg R
J Cell Biochem; 1995 Dec; 59(4):537-44. PubMed ID: 8749722
[TBL] [Abstract][Full Text] [Related]
5. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
[TBL] [Abstract][Full Text] [Related]
6. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
8. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
Wang NP; To H; Lee WH; Lee EY
Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
Isaacs WB; Carter BS; Ewing CM
Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816
[TBL] [Abstract][Full Text] [Related]
11. Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.
Frebourg T; Sadelain M; Ng YS; Kassel J; Friend SH
Cancer Res; 1994 Feb; 54(4):878-81. PubMed ID: 8313374
[TBL] [Abstract][Full Text] [Related]
12. Growth suppression of normal mammary epithelial cells by wild-type p53.
Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE
Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256
[TBL] [Abstract][Full Text] [Related]
13. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
14. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
Qazilbash MH; Xiao X; Seth P; Cowan KH; Walsh CE
Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168
[TBL] [Abstract][Full Text] [Related]
15. Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells.
Courtois SJ; Woodworth CD; Degreef H; Garmyn M
Exp Cell Res; 1997 May; 233(1):135-44. PubMed ID: 9184083
[TBL] [Abstract][Full Text] [Related]
16. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
19. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
20. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
